First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-08-12 08:05:56Open Document File Size: 444,08 KBShare Result on FacebookCityWashington / DC / Amsterdam / Boston / /CompanyBOC / /ContinentEurope / /CountryNetherlands / United Kingdom / /CurrencyGBP / / /IndustryTermtreatment of Hepatitis C / therapies for liver cancer / /MedicalConditionadvanced disease / previously untreated chronic hepatitis C / bacterial infections / disease / HCV Genotype 1 / advanced cirrhosis / severe cirrhosis / Forns X. Viral hepatitis / cirrhosis / England A02/PS/b Chronic infection / Hepatitis C / HCV / recurrent hepatitis C. Liver / significant cirrhosis / HCV infection / encephalopathy / liver cancer / Infectious Diseases / infection / MS / Liver Disease / HCV Genotype 2 / hepatic decompensation / chronic hepatitis C / /MedicalTreatmentliver transplants / liver transplant / Antiviral therapy / /OrganizationEuropean Medicines Agency / American Association for the Study of Liver Diseases / International Liver Transplantation Society / NHS / American Association for the Study / /PersonBerenguer M. Natural history / /PositionAuthor / CCG Chief / MP / /Productribavirin / /TechnologyGPS / transplantation / genotype / /SocialTag |